Rvl Pharmaceuticals Plc Asset Turnover Ratio (RVLP), as of second quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Rvl Pharmaceuticals Plc  (NASDAQ: RVLP)
 

Rvl Pharmaceuticals Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Rvl Pharmaceuticals Plc asset turnover ratio, the ability of Rvl Pharmaceuticals Plc's assets to generate revenue in the second quarter 2023, increased sequentially to 0.3 in the second quarter (Jun 30 2023), yet the ratio remained below the average, as RVLP's position remain challenging.

Within sector 34 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2023 compared to the preceding quarter from 789 to 870.

Asset Turnover Ratio Definition



RVLP Asset Turnover Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Asset Change -31.58 % -23.01 % -11.03 % 41.95 % -62.74 %
Y / Y Revenue Change -13.45 % -58.81 % 242.9 % 356.38 % -26.6 %
Asset Turnover Ratio (TTM) 0.3 0.29 0.36 0.3 0.27
RVLP's Total Ranking # 870 # 789 # 2783 # 1776 # 3145
Seq. Asset Change -23.13 % -13.54 % -17.28 % 24.45 % -13.5 %
Seq. Revenue Change -17.21 % -9.94 % -2.15 % 18.63 % -60.6 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 35
Healthcare Sector # 75
Overall Market # 870

Asset Turnover Ratio Statistics
High Average Low
71.38 16.96 2.86
(Jun 30 2021)   (Jun 30 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2023 Assets at quarter ending Jun 30 2023
Eton Pharmaceuticals Inc   1.13 $ 28.703  Millions$ 25.353  Millions
Warby Parker Inc   1.13 $ 632.873  Millions$ 559.612  Millions
Amedisys Inc  1.13 $ 2,229.409  Millions$ 1,971.933  Millions
Electromed Inc   1.13 $ 48.067  Millions$ 42.536  Millions
Cerus Corporation  1.13 $ 237.384  Millions$ 210.423  Millions
P3 Health Partners Inc   1.13 $ 1,137.636  Millions$ 1,009.021  Millions
Adm Tronics Unlimited Inc   1.13 $ 3.518  Millions$ 3.122  Millions
Puma Biotechnology Inc   1.13 $ 230.120  Millions$ 204.395  Millions
Biotricity Inc   1.12 $ 10.500  Millions$ 9.346  Millions
Zeo Scientifix Inc   1.12 $ 4.580  Millions$ 4.077  Millions
Nrc Health  1.11 $ 148.469  Millions$ 133.344  Millions
Lftd Partners Inc   1.11 $ 47.535  Millions$ 42.974  Millions
Xtant Medical Holdings Inc   1.10 $ 67.135  Millions$ 61.203  Millions
Agile Therapeutics Inc  1.09 $ 16.006  Millions$ 14.743  Millions
Docgo Inc   1.09 $ 419.818  Millions$ 386.757  Millions
Thorne Healthtech Inc   1.08 $ 255.948  Millions$ 236.098  Millions
Nephros Inc   1.08 $ 11.743  Millions$ 10.912  Millions
Orasure Technologies Inc  1.07 $ 479.875  Millions$ 447.481  Millions
Addus Homecare Corp  1.07 $ 999.125  Millions$ 935.849  Millions
Imac Holdings Inc   1.07 $ 10.695  Millions$ 10.025  Millions
Irhythm Holdings Inc   1.04 $ 451.153  Millions$ 434.950  Millions
Rigel Pharmaceuticals Inc  1.03 $ 126.644  Millions$ 122.648  Millions
Nabriva Therapeutics Plc  1.03 $ 29.557  Millions$ 28.730  Millions
Yunhong Green Cti Ltd   1.03 $ 16.398  Millions$ 15.946  Millions
Electromedical Technologies Inc   1.03 $ 1.376  Millions$ 1.340  Millions
Aveanna Healthcare Holdings Inc   1.02 $ 1,832.514  Millions$ 1,789.356  Millions
Phibro Animal Health Corporation  1.02 $ 977.237  Millions$ 954.227  Millions
Healthlynked Corp  1.02 $ 6.061  Millions$ 5.932  Millions
Lifeloc Technologies Inc   1.02 $ 8.586  Millions$ 8.406  Millions
Universal Health Services Inc   1.02 $ 13,798.663  Millions$ 13,540.339  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.